Quantitative Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.28M | Sell |
3,857
-474
| -11% | -$161K | 0.13% | 187 |
|
|
2025
Q4 | $1.72M | Buy |
+4,331
| New | +$1.92M | 0.17% | 129 |
|
|
2025
Q3 | – | Sell |
-1,238
| Closed | -$403K | – | 333 |
|
|
2025
Q2 | $403K | Buy |
+1,238
| New | +$343K | 0.05% | 225 |
|
|
2025
Q1 | – | Sell |
-11,010
| Closed | -$2.59M | – | 328 |
|
|
2024
Q4 | $2.59M | Buy |
11,010
+10,208
| +1,273% | +$2.68M | 0.19% | 105 |
|
|
2024
Q3 | $220K | Sell |
802
-8,534
| -91% | -$2.22M | 0.02% | 301 |
|
|
2024
Q2 | $2.27M | Buy |
9,336
+5,867
| +169% | +$926K | 0.25% | 81 |
|
|
2024
Q1 | $518K | Buy |
+3,469
| New | +$579K | 0.03% | 208 |
|
|
2021
Q4 | – | Sell |
-14,293
| Closed | -$2.7M | – | 238 |
|
|
2021
Q3 | $2.7M | Sell |
14,293
-9,032
| -39% | -$1.69M | 0.24% | 87 |
|
|
2021
Q2 | $3.95M | Buy |
23,325
+7,474
| +47% | +$1.09M | 0.36% | 71 |
|
|
2021
Q1 | $2.24M | Buy |
15,851
+9,979
| +170% | +$1.5M | 0.19% | 140 |
|
|
2020
Q4 | $763K | Buy |
+5,872
| New | +$784K | 0.06% | 280 |
|
|
2020
Q3 | – | Sell |
-40,945
| Closed | -$6.06M | – | 386 |
|
|
2020
Q2 | $6.06M | Buy |
40,945
+20,207
| +97% | +$2.72M | 0.62% | 26 |
|
|
2020
Q1 | $2.26M | Sell |
20,738
-110,054
| -84% | -$12.7M | 0.25% | 102 |
|
|
2019
Q4 | $15.1M | Buy |
130,792
+62,784
| +92% | +$6.26M | 0.46% | 54 |
|
|
2019
Q3 | $5.47M | Buy |
+68,008
| New | +$5.38M | 0.29% | 95 |
|
|
2019
Q2 | – | Sell |
-12,000
| Closed | -$1.12M | – | 610 |
|
|
2019
Q1 | $1.12M | Sell |
12,000
-7,900
| -40% | -$661K | 0.06% | 352 |
|
|
2018
Q4 | $1.45M | Buy |
+19,900
| New | +$1.53M | 0.07% | 235 |
|
|
2018
Q2 | – | Sell |
-57,800
| Closed | -$6.88M | – | 714 |
|
|
2018
Q1 | $6.88M | Buy |
57,800
+53,900
| +1,382% | +$6.95M | 0.12% | 214 |
|
|
2017
Q4 | $495K | Sell |
3,900
-1,000
| -20% | -$126K | 0.01% | 669 |
|
|
2017
Q3 | $575K | Buy |
+4,900
| New | +$418K | 0.01% | 602 |
|
|
2017
Q1 | – | Sell |
-98,400
| Closed | -$3.68M | – | 674 |
|
|
2016
Q4 | $3.68M | Buy |
98,400
+89,800
| +1,044% | +$3.76M | 0.09% | 342 |
|
|
2016
Q3 | $582K | Buy |
+8,600
| New | +$607K | 0.02% | 514 |
|
|
2016
Q1 | – | Sell |
-9,300
| Closed | -$875K | – | 751 |
|
|
2015
Q4 | $875K | Sell |
9,300
-7,000
| -43% | -$649K | 0.05% | 389 |
|
|
2015
Q3 | $1.31M | Buy |
+16,300
| New | +$1.81M | 0.1% | 255 |
|
|
2015
Q1 | – | Sell |
-3,300
| Closed | -$320K | – | 609 |
|
|
2014
Q4 | $320K | Sell |
3,300
-500
| -13% | -$46.3K | 0.05% | 337 |
|
|
2014
Q3 | $296K | Sell |
3,800
-7,100
| -65% | -$458K | 0.06% | 249 |
|
|
2014
Q2 | $688K | Buy |
+10,900
| New | +$648K | 0.12% | 175 |
|
Other funds holding ALNY
VPM
VCM
